Optimising the Cancer Management of Older Patients by Early and Specific Geriatric Interventions.
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age75+
SponsorPoitiers University Hospital
About this trial
The WARNING project proposes a new care organisation for older patients with cancer. The aim is to optimise management in daycare with early detection signs of geriatric syndromes and specific interventions. This prevention package, called the 'WARNING Pack', includes a specific multimodal geriatric management guide for the oncologist (physician form), based on patient-reported early geriatric warning signs (patient form). Primary outcome is to reduce the risk of deterioration in global quality of life at 6 months during treatment and to prevent the onset of geriatric syndromes.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥75 years.
Patients with confirmed solid cancer or haematological malignancy, regardless of
the site of the tumour (single or multiple), - the duration of the disease, or - the treatment modality (adjuvant, neoadjuvant, locally advanced, palliative metastatic).
Patients starting a first line of systemic treatment or a new line of treatment after a break of at least six months.
Disqualifiers
Patients under legal protection (guardianship, curatorship).
Persons with enhanced protection, i.e. persons deprived of their liberty by a judicial or administrative decision, persons in a health or social care institution, persons under legal protection and patients in emergency situations.
Trial design
Design model
Parallel
Treatments tested in this trial
WARNING Pack
Other interventionThis prevention package, called the 'WARNING Pack', includes a specific multimodal geriatric management guide for the oncologist (physician form), based on patient-reported early geriatric warning signs (patient form).
Treatment groups
1,010 Participants
are divided into 2 treatment groupsGroup A: the experimental group, the WARNING packExperimental treatment 1 intervention
Group B: Standard groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Proportion of patients with unchanged or improved global quality of life between M0 and M6.
Time frame
6 monthLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: